This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) Q2 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) adjusted net investment income declines on reduced variable investment income, stemming from decreased private equity returns.
Can EverQuote (EVER) Climb 42% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 42.4% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
EverQuote (EVER) Q2 Loss Narrower Than Expected, View Tweaked
by Zacks Equity Research
EverQuote's (EVER) Q2 results witnessed lower revenues from Automotive insurance but higher revenues in the Other insurance vertical. Expenses decreased.
EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why Is EverQuote (EVER) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up (Revised)
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y (Revised)
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
EverQuote (EVER) Q1 Loss Lower Than Expected, Revenues Up Y/Y
by Zacks Equity Research
EverQuote's (EVER) 1Q results reflect higher revenues from Automotive insurance and Other insurance verticals in the reported quarter, partially offset by higher expenses.
EverQuote (EVER) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 26.92% and 8.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Community West Bancshares (CWBC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Community West Bancshares (CWBC) delivered earnings and revenue surprises of 28.57% and 1.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for EverQuote (EVER) This Earnings Season?
by Zacks Equity Research
EverQuote (EVER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
EverQuote (EVER) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
EverQuote (EVER) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EverQuote (EVER) Down 8.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from strategic acquisitions, improved guidance and sufficient liquidity.
EverQuote (EVER) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EverQuote's (EVER) Q4 results reflect growth in the Variable Marketing Margin and a solid performance in the other insurance vertical.
EverQuote (EVER) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 9.38% and 5.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate EverQuote (EVER) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
EverQuote (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from improvements in traffic volumes and monetization, improved guidance and sufficient liquidity.
Why Is EverQuote (EVER) Up 4.6% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
EverQuote (EVER) Q3 Loss Wider Than Expected, Revenues Up Y/Y
by Zacks Equity Research
EverQuote (EVER) Q3 results reflect higher variable marketing margin, offset by higher costs and operating expenses in the reported quarter.
Analysts Estimate EverQuote (EVER) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
EverQuote (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.